SeaCrest Wealth Management’s CareDx CDNA Stock Holding History

SeaCrest Wealth Management’s Portfolio CDNA Stock Details CDNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-100	Closed	-$3K	–	722
2019 Q1	$3K	Buy	+100	New	+$2.91K	﹤0.01%	1828

Other funds holding CDNA

FAM

Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

WRF

Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return

Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Gagnon Securities New York $433M AUM 29.08% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

SeaCrest Wealth Management's CDNA Position: Q2 2019 in Review

SeaCrest Wealth Management sold out of CareDx (CDNA) in Q2 2019, closing a stake of 100 shares — an estimated $3K sold.

SeaCrest Wealth Management first reported a position in CDNA in Q1 2019 and held it in 1 quarter. The position peaked at $3K in Q1 2019. 182 funds tracked by Wall St. Rank hold CDNA as of Q2 2019.

SeaCrest Wealth Management reported no remaining CareDx position as of Q2 2019 after selling out during the quarter.
SeaCrest Wealth Management sold 100 CareDx shares in Q2 2019, an estimated $3K.
SeaCrest Wealth Management first reported a position in CareDx in Q1 2019 and held it in 1 quarter.
SeaCrest Wealth Management's CareDx position peaked at $3K in Q1 2019.
182 funds tracked by Wall St. Rank held CareDx as of Q2 2019.

Based on SeaCrest Wealth Management's 13F filing for Q2 2019, filed 19 Jul 2019.